8th Circ. Won't Rehear KV Drug Recall Action

Law360, New York (May 11, 2011, 9:24 PM EDT) -- The Eighth Circuit on Wednesday declined to reconsider greenlighting a product liability class action against KV Pharmaceutical Co. over recalls of a drug that treats high blood pressure.

The Eighth Circuit will not grant a rehearing or en banc rehearing of its January decision to revive the class action, filed after the U.S. Food and Drug Administration requested recalls of metoprolol succinate ER. Circuit Judge Steven Colloton, who did not sit on the original three-judge panel, was the only judge to support the idea of a...
To view the full article, register now.




Case Information

Case Title

Lefaivre v. KV Pharmaceutical Company, et al.

Case Number



Missouri Eastern

Nature of Suit

Tort Product Liability


Stephen N. Limbaugh, Jr

Date Filed

April 15, 2009

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.